Glucagon-like peptide-1 (GLP-1) peptides have emerged as a compelling therapeutic target for managing metabolic syndromes. These naturally occurring substances are secreted by the gut in response to nutrient intake, https://olivebookmarks.com/story20552360/unveiling-the-therapeutic-potential-of-glp-1-peptides